Data-driven pharmaceutical intelligence for biotech investors, pharma operators, consultants, and intelligence teams.

Weekly intelligence for pharma decision-makers.

No paywall. No spam. Unsubscribe anytime.

Intelligence powered by the Humanexa engine.

Therapeutic Area

Laxative

Therapeutic area intelligence for Laxative with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Companies

StrategyAugust 2, 2026

The FDA has granted approval for ANDA217505, a generic formulation of Polyethylene Glycol 3350 by LNK INTL INC.

RegulatoryJuly 26, 2026

The FDA has an active application for Lactulose (ANDA074712) submitted by Cumberland Pharmaceuticals, currently under standard review.

StrategyJuly 3, 2026

The FDA has granted an Abbreviated New Drug Application (ANDA) approval status for Lactulose submitted by Cumberland Pharmaceuticals.

No catalysts indexed for this entity yet.

No related entities indexed yet.

Newsletter

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.